ARTV
Price
$4.03
Change
+$0.16 (+4.13%)
Updated
Feb 6 closing price
Capitalization
98.92M
49 days until earnings call
Intraday BUY SELL Signals
TCRX
Price
$1.03
Change
+$0.12 (+13.19%)
Updated
Feb 6 closing price
Capitalization
57.15M
30 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARTV vs TCRX

Header iconARTV vs TCRX Comparison
Open Charts ARTV vs TCRXBanner chart's image
Artiva Biotherapeutics
Price$4.03
Change+$0.16 (+4.13%)
Volume$145.05K
Capitalization98.92M
TScan Therapeutics
Price$1.03
Change+$0.12 (+13.19%)
Volume$1.08M
Capitalization57.15M
ARTV vs TCRX Comparison Chart in %
ARTV
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ARTV vs. TCRX commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTV is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (ARTV: $4.03 vs. TCRX: $1.03)
Brand notoriety: ARTV and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTV: 11% vs. TCRX: 179%
Market capitalization -- ARTV: $98.92M vs. TCRX: $57.15M
ARTV [@Biotechnology] is valued at $98.92M. TCRX’s [@Biotechnology] market capitalization is $57.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTV’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • ARTV’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, ARTV is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTV’s TA Score shows that 3 TA indicator(s) are bullish while TCRX’s TA Score has 5 bullish TA indicator(s).

  • ARTV’s TA Score: 3 bullish, 4 bearish.
  • TCRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TCRX is a better buy in the short-term than ARTV.

Price Growth

ARTV (@Biotechnology) experienced а +3.60% price change this week, while TCRX (@Biotechnology) price change was +0.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

ARTV is expected to report earnings on Mar 30, 2026.

TCRX is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARTV($98.9M) has a higher market cap than TCRX($57.1M). TCRX YTD gains are higher at: 3.000 vs. ARTV (-6.061). ARTV has higher annual earnings (EBITDA): -83.6M vs. TCRX (-136.89M). TCRX has more cash in the bank: 184M vs. ARTV (123M). ARTV has less debt than TCRX: ARTV (11.7M) vs TCRX (95.6M). TCRX has higher revenues than ARTV: TCRX (8.42M) vs ARTV (0).
ARTVTCRXARTV / TCRX
Capitalization98.9M57.1M173%
EBITDA-83.6M-136.89M61%
Gain YTD-6.0613.000-202%
P/E RatioN/AN/A-
Revenue08.42M-
Total Cash123M184M67%
Total Debt11.7M95.6M12%
TECHNICAL ANALYSIS
Technical Analysis
ARTVTCRX
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 19 days ago
86%
Bullish Trend 19 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARTV
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OFSTF0.620.01
+2.24%
Carbon Streaming Corporation
GENSY42.140.28
+0.67%
Genus Plc
KGTFY16.70N/A
N/A
Krung Thai Bank Public Co., Ltd.
SRBIF3.55N/A
N/A
Serabi Gold Plc
EBRGF15.55N/A
N/A
Enbridge Inc.

ARTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTV has been closely correlated with QNCX. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARTV jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTV
1D Price
Change %
ARTV100%
+4.13%
QNCX - ARTV
94%
Closely correlated
-4.79%
MREO - ARTV
89%
Closely correlated
+13.20%
TPST - ARTV
89%
Closely correlated
+7.62%
CALC - ARTV
89%
Closely correlated
-1.77%
BDRX - ARTV
82%
Closely correlated
-4.62%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been closely correlated with VTGN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCRX jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+13.14%
VTGN - TCRX
70%
Closely correlated
+11.52%
RZLT - TCRX
70%
Closely correlated
+6.85%
ARTV - TCRX
69%
Closely correlated
+4.13%
ARCT - TCRX
69%
Closely correlated
+7.83%
TPST - TCRX
67%
Closely correlated
+7.62%
More